A review of liver fibrosis and cirrhosis regression
- PMID: 37461143
- PMCID: PMC10369136
- DOI: 10.4132/jptm.2023.05.24
A review of liver fibrosis and cirrhosis regression
Abstract
Cirrhosis has traditionally been considered an irreversible process of end-stage liver disease. With new treatments for chronic liver disease, there is regression of fibrosis and cirrhosis, improvement in clinical parameters (i.e. liver function and hemodynamic markers, hepatic venous pressure gradient), and survival rates, demonstrating that fibrosis and fibrolysis are a dynamic process moving in two directions. Microscopically, hepatocytes push into thinning fibrous septa with eventual perforation leaving behind delicate periportal spikes in the portal tracts and loss of portal veins. Obliterated portal veins during progressive fibrosis and cirrhosis due to parenchymal extinction, vascular remodeling and thrombosis often leave behind a bile duct and hepatic artery within the portal tract. Traditional staging classification systems focused on a linear, progressive process; however, the Beijing classification system incorporates both the bidirectional nature for the progression and regression of fibrosis. However, even with regression, vascular lesions/remodeling, parenchymal extinction and a cumulative mutational burden place patients at an increased risk for developing hepatocellular carcinoma and should continue to undergo active clinical surveillance. It is more appropriate to consider cirrhosis as another stage in the evolution of chronic liver disease as a bidirectional process rather than an end-stage, irreversible state.
Keywords: Cirrhosis; Fibrosis; Liver.
Conflict of interest statement
The authors declare that they have no potential conflicts of interest.
Figures







Similar articles
-
Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.Adv Anat Pathol. 2021 Nov 1;28(6):408-414. doi: 10.1097/PAP.0000000000000312. Adv Anat Pathol. 2021. PMID: 34326286 Free PMC article. Review.
-
Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis.Diagnostics (Basel). 2021 Jun 28;11(7):1171. doi: 10.3390/diagnostics11071171. Diagnostics (Basel). 2021. PMID: 34203262 Free PMC article.
-
Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver.Pathol Res Pract. 2001;197(2):65-76. doi: 10.1078/0344-0338-5710012. Pathol Res Pract. 2001. PMID: 11261820 Review.
-
Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.Arch Pathol Lab Med. 2000 Nov;124(11):1599-607. doi: 10.5858/2000-124-1599-ROHC. Arch Pathol Lab Med. 2000. PMID: 11079009
-
Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).Hepatology. 1995 May;21(5):1232-7. Hepatology. 1995. PMID: 7737628
Cited by
-
AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis.Cells. 2023 Aug 22;12(17):2127. doi: 10.3390/cells12172127. Cells. 2023. PMID: 37681859 Free PMC article.
-
Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes.Life (Basel). 2025 May 13;15(5):779. doi: 10.3390/life15050779. Life (Basel). 2025. PMID: 40430206 Free PMC article. Review.
-
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun. Liver Res. 2025. PMID: 40620504 Free PMC article. Review.
-
Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.Int J Mol Sci. 2024 Aug 8;25(16):8641. doi: 10.3390/ijms25168641. Int J Mol Sci. 2024. PMID: 39201329 Free PMC article. Review.
-
Multiomic predictors for regression of cirrhosis: Clinical implications and future directions.ILIVER. 2024 Sep 7;3(4):100116. doi: 10.1016/j.iliver.2024.100116. eCollection 2024 Dec. ILIVER. 2024. PMID: 40635855 Free PMC article. No abstract available.
References
-
- MacSween RN, Burt AD, Portman B, et al. Pathology of the liver. 4th ed. Philadelphia: Saunders; 2002.
-
- Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med. 2000;124:1599–607. - PubMed
-
- Hutterer F, Rubin E, Popper H. Mechanism of collagen resorption in reversible hepatic fibrosis. Exp Mol Pathol. 1964;3:215–23. - PubMed
-
- Brody JI, Mc KD, Kimball SG. Therapeutic phlebotomies in idiopathic hemochromatosis. Am J Med Sci. 1962;244:575–86. - PubMed
-
- Perez-Tamayo R. Cirrhosis of the liver: a reversible disease? Pathol Annu. 1979;14 Pt 2:183–213. - PubMed
Publication types
LinkOut - more resources
Full Text Sources